MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor
- B1174 LGX818Target: RafSummary: RAF inhibitor,potent and selective
- B1135 GDC-0623Target: MEKSummary: MEK1 inhibitor, potent and ATP-uncompetitive
- B1106 VRT752271Target: ERKSummary: ERK1/ERK2 inhibitor
- B2190 H 89 2HCl3 CitationSummary: Potent PKA inhibitor
- B9000 8-Bromo-cAMP, sodium saltTarget: PKASummary: Cell-permeable cAMP analog that activates PKA
- B9001 Dibutyryl-cAMP, sodium saltSummary: Cell-permeable cAMP analog that activates cAMP-dependent protein kinases
- B9002 KT 5720Summary: protein kinase A inhibitor, potent and selective
- B9003 cAMPS-Sp, triethylammonium saltSummary: Cell-permeable cAMP analog that activates cAMP receptor protein PKA
- B9004 cAMPS-Rp, triethylammonium saltSummary: Cell-permeable cAMP analog, competitive antagonist of cAMP-induced activation of PKA